London Digestive Disease Institute — London, Ontario

Public research footprint of London Digestive Disease Institute, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Most-studied conditions

Ulcerative Colitis · Crohn Disease · Ulcerative Colitis (UC) · Obesity or Overweight

Recently updated registry entries

NCT07483099 — A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone)… (Recruiting)
NCT07415044 — LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis (Recruiting)
NCT06937099 — Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at London Digestive Disease Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.